Supply Chain Planning and Clinical Trials Adaptive Design

2 min read

It is time for cheaper, faster, more granular, and more precise clinical trials Discovering new drugs, repurposing or repositioning existing ones, and reducing healthcare costs require cheaper, faster, more granular, and more precise clinical trials without compromising safety. While advances in digital technology hold promise, life science organizations are contingent on rethinking research designs in light of new patient-centric characteristics. Why Adaptive Design Resizing the sample, discontinuing treatments or doses, adjusting the ratio of patients to study arms, focusing recruitment efforts on patients most likely to benefit, and stopping the trial early for success or lack of efficacy. All of these adjustments…...

This article is free to read

Login to read the full article

Flavio Aliberti Flavio Aliberti brings with him a 22-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.

Schedule a DDIChat with Flavio Aliberti